Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also recognized as PingAn Good Doctor, has entered into a partnership with Japanese firm Chugai Pharmaceutical to jointly establish an angina pectoris center. This collaboration aims to integrate medical expertise with technological innovation to enhance coronary heart disease management.
Advancing Coronary Heart Disease Diagnosis and Treatment
The newly established center will capitalize on the advantages of Internet medicine to create an online standardized diagnosis and treatment path for coronary heart disease. It will develop a comprehensive management service system that covers all aspects of patient care, from diagnosis to post-operative management.
Combining Expertise and AI Technology
The center will mobilize a team of cardiologists with experience from Class 3A hospitals, ensuring high-quality medical care. An AI-intelligent follow-up system will be implemented to provide health education for patients with coronary heart disease. The system will also develop personalized management plans that consider various dimensions, including prevention, monitoring, exercise, nutrition, and medication.
Enhancing Patient Outcomes and Experience
This partnership between Ping An Healthcare and Technology and Chugai Pharmaceutical signifies a significant step towards improving the lives of patients with coronary heart disease. By combining medical expertise with advanced AI technology, the center aims to offer a holistic approach to patient care, enhancing both treatment outcomes and the overall patient experience.-Fineline Info & Tech
